Important pharmaceutical organizations have demonstrated they can utilize the courts as well as ITC to safeguard patented compounds. The legal runway for grey-market functions is shrinking.This isn't the tip of peptide accessibility. The February 2026 reclassification restored compounding legal rights for most favored peptides.Huberman’s comment